Frontal Fibrosing Alopecia Clinical Trial
Official title:
A Pilot Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)
The goal of this clinical trial is to evaluate the safety and efficacy of Baricitinib in the treatment of frontal fibrosing alopecia (FFA).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04409041 -
Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia
|
Phase 2 | |
| Completed |
NCT03630198 -
Pain Outcomes Following Intralesional Corticosteroid Injections
|
Phase 4 | |
| Enrolling by invitation |
NCT06202560 -
Effectiveness and Safety of Tofacitinib in Patients With Recalcitrant Frontal Fibrosing Alopecia : A Pilot Study
|
N/A | |
| Not yet recruiting |
NCT03335228 -
Platelet Rich Plasma for Frontal Fibrosing Alopecia
|
N/A | |
| Not yet recruiting |
NCT02467101 -
Study to Assess the Efficacy of Intralesional Corticosteroid on the Treatment of Frontal Fibrosing Alopecia
|
N/A | |
| Recruiting |
NCT03422640 -
Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia
|
Phase 4 | |
| Completed |
NCT03346668 -
Role of Neurogenic Inflammation and Topical 6% Gabapentin Therapy in Symptomatic Scarring Alopecia
|
Early Phase 1 | |
| Active, not recruiting |
NCT03082560 -
Design and Validation of a New Assessment Tool for Lichen Planopilaris
|
||
| Completed |
NCT04342091 -
Follicular Revival in Fibrosing Alopecia: Evaluating Use of Micro-needling
|
N/A | |
| Completed |
NCT05332366 -
A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia
|
Phase 2 |